Efficacy and safety of rt-PA (Alteplase®) plus heparin vs heparin alone in pulmonary embolism (PE): PAIMS-2 results

Antonio Palla; Sergio Dalla Volta; A. Santolicandro; C. Giuntini; Vittorio Pengo; O Visioli; Pietro Zonzin; D Zanuttini; F Barbaresi; Giancarlo Agnelli; M Morpurgo; M. Marini; Luigi Visani

Back

Efficacy and safety of rt-PA (Alteplase®) plus heparin vs heparin alone in pulmonary embolism (PE): PAIMS-2 results

Article 1992 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1992

PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2

Sergio Dalla‐Volta, Antonio Palla, Annamaria Santolicandro, Carlo Giuntini, Vittorio Pengo, O Visioli, Pietro Zonzin, D Zanuttini, F Barbaresi, Giancarlo Agnelli, M Morpurgo, Maria Giulia Marini, Luigi Visani

Article2002

Thrombolysis vs Heparin in the Treatment of Pulmonary Embolism

Giancarlo Agnelli, Cecilia Becattini, Timo Kirschstein

Article1997

Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism

Giancarlo Agnelli, Alfonso Iorio, Pasquale Parise, Samuel Z. Goldhaber, M N Levine

Article2014

Efficacy and safety of direct oral anticoagulants after pulmonary embolism: A meta-analysis

Maria Cristina Vedovati, Cecilia Becattini, Federico Germini, Giancarlo Agnelli

Article2022

Safety and efficacy of durvalumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from the phase 2 study 22 (NCT02519348).

Ho Yeong Lim, Jeong Heo, Tae‐You Kim, Wai Meng David Tai, Yoon‐Koo Kang, George Lau, Masatoshi Kudo, Won Young Tak, Magdalena Watras, S. Ali, Alejandra Negro, Ghassan K. Abou‐Alfa, Robin Kate Kelley